News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-11-01-2017
Volume12
Issue 11

Lonza to Acquire Manufacturing Facility from Shire

Lonza has announced plans to acquire a clinical-stage mammalian manufacturing facility in the United States from Shire.

On Oct. 3, 2017, Lonza announced the acquisition of a clinical-stage mammalian manufacturing facility in the United States from Shire, a biotechnology company focused on developing therapies for rare diseases. Financial details of the deal were not disclosed.

The 58,000-ft2 (approximately 5,388-m2) site, located in Hayward, CA, has been operating as a multiproduct cGMP facility since 1990. Assets include 1,000-L and 2,000-L single-use bioreactors and associated downstream capabilities. This acquisition will provide added cGMP capacity and will supplement existing assets in Lonza’s UK site at Slough, Berkshire. Lonza customer batches will be initiated in 2018. The Hayward site’s more than 100 current employees will continue their roles under Lonza.

“As a committed partner to the pharmaceutical and biotechnology industry, Lonza recognizes the need for established and dependable global manufacturing facilities,” said Karen Fallen, vice president, business unit head, clinical development, for Lonza, in a company press release. "The acquisition of this site allows our customers greater access to clinical capacity from a US site. The additional capacity will support the needs of our customers to secure manufacture for their products’ complete lifecycle across Lonza’s global manufacturing network."

Source: Lonza

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content